Den europeiske union - norsk - EMA (European Medicines Agency)

pfizer europe ma eeig - bosutinib (som monohydrat) - leukemi, myeloid - antineoplastic agents, protein kinase inhibitors - bosulif er indisert for behandling av voksne pasienter med nylig diagnostisert kronisk fase (cp) philadelphia kromosom-positiv kronisk myelogen leukemi (ph+ cml). cp, akselerert fase (ap), og blast fase (bp) ph+ cml som tidligere er behandlet med ett eller flere tyrosin kinase inhibitor(s) [tki(s)], og for hvem imatinib, nilotinib og dasatinib er ikke anses hensiktsmessig behandlingstilbud.

Norge - norsk - Statens legemiddelverk

abacus medicine a/s - bosutinibmonohydrat - tablett, filmdrasjert - 400 mg

Norge - norsk - Statens legemiddelverk

2care4 aps - bosutinibmonohydrat - tablett, filmdrasjert - 100 mg

Norge - norsk - Statens legemiddelverk

2care4 aps - bosutinibmonohydrat - tablett, filmdrasjert - 400 mg

Den europeiske union - norsk - EMA (European Medicines Agency)

sfl pharmaceuticals deutschland gmbh - nyxthracis - anthrax - immune sera og immunglobuliner, - obiltoxaximab sfl is indicated in combination with appropriate antibacterial drugs in all age groups for treatment of inhalational anthrax due to bacillus anthracis (see section 5. obiltoxaximab sfl is indicated in all age groups for post-exposure prophylaxis of inhalational anthrax when alternative therapies are not appropriate or are not available (see section 5.

Den europeiske union - norsk - EMA (European Medicines Agency)

siga technologies netherlands b.v. - tecovirimat - poxviridae infections; cowpox; monkeypox; vaccinia; smallpox - antivirale midler til systemisk bruk - tecovirimat siga is indicated for the treatment of the following viral infections in adults and children with body weight at least 13 kg:- smallpox- monkeypox- cowpoxtecovirimat siga is also indicated to treat complications due to replication of vaccinia virus following vaccination against smallpox in adults and children with body weight at least 13 kg (see sections 4. 4 og 5. tecovirimat siga should be used in accordance with official recommendations.

Norge - norsk - Statens legemiddelverk

mallinckrodt medical b.v. - gallium (67ga) sitrat - injeksjonsvæske, oppløsning - 37 mbq/ ml

Norge - norsk - Statens legemiddelverk

curium netherlands b.v. - indium (111in) oksin - oppløsning - 37 mbq/ ml

Norge - norsk - Statens legemiddelverk

glenmark arzneimittel gmbh - rosuvastatinkalsium - tablett, filmdrasjert - 40 mg

Norge - norsk - Statens legemiddelverk

glenmark arzneimittel gmbh - rosuvastatinkalsium - tablett, filmdrasjert - 5 mg